搜尋結果
Repatha (evolocumab): Adults w/ primary hypercholesterolaemia (heterozygous familial & non-familial) or mixed dyslipidaemia, & paed ≥10 yr w/ het.
Relief of mild to moderate pain of muscle spasm associated w/ acute painful musculoskeletal conditions eg, strain, sprain & cramps, & other injuries of skeleton muscle. Click to view Pormus detailed prescribing information.
Indications and Dosage. Oral. Cough. Adult: 60 mg up to tid at intervals of at least 6 hours. Dosage recommendations may vary among countries or individual products (refer to specific product guidelines). Child: 2-12 years 1 mg/kg/dose up to tid at intervals of at least 6 hours. Max: 3 mg/kg daily. >12 years Same as adult dose.
Contents. Insulin degludec. Indications/Uses. DM in adults, adolescents & childn ≥1 yr. Click to view Tresiba detailed prescribing information. Dosage/Direction for Use. SC Type 2 DM Initially 10 u followed by individual dose adjustments. Can be administered alone, or in combination w/ oral antidiabetics, GLP-1 receptor agonists & bolus insulin.
Indications/Uses. Adjunct to diet & exercise in adults w/ insufficiently controlled type 2 DM given as monotherapy when metformin is considered inappropriate due to intolerance; in addition to other medicinal products for treatment of type 2 diabetes.
Contents. Per tab Dihydrocodeine bitartrate 5 mg, guaifenesin 50 mg, DL-methylephedrine HCl 17.5 mg, chlorpheniramine maleate 1.5 mg. Per 100 mL syrup Dihydrocodeine bitartrate 50 mg, DL-methylephedrine HCl 131.25 mg, guaifenesin 375 mg, chlorpheniramine maleate 15 mg.
Indications/Uses. Adjuvant treatment after complete tumour resection in adults w/ stage IB-IIIA NSCLC whose tumours have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations. 1st-line treatment of adults w/ locally advanced or metastatic NSCLC w/ activating EGFR mutations.
